Find trials
Consejos para buscar

A Study to Evaluate the Pharmacist Role and Pharmacogenomics in the Care of Seriously Ill Patients

Overview

Información sobre este estudio

The purposes of this study are to evaluate: 

  • The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management;
  • Patient perceptions, satisfaction and behaviors related to their medications and their view of the helpfulness of the pharmacist,
  • The impact that a clinical pharmacist and pharmacogenomic testing has on overall cost of care; and
  • The impact that a clinical pharmacist and pharmacogenomic testing has on average cost of medications.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • English speaking.
  • Age 18 years and older.
  • Palliative Medicine is consulted for the first time in either the outpatient setting for symptom management and plan to continue to follow up with the Palliative Medicine team in the outpatient setting for the foreseeable future.
  • Insurance accepted at Mayo Clinic Arizona.
  • Live within metro Phoenix area.

Exclusion Criteria: 

  • Vulnerable adults.
  • Under 18 years of age.
  • Pregnant patients.
  • Non-English speaking patients.
  • Patients that lack capacity for medical decision making.
  • Patients who live outside the metro Phoenix area.
  • Patients who are lost to follow up secondary to enrolling in hospice, die or fail to show or answer surveys within 2 months of enrollment.
  • Patients with uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent.
  • Patients previously established within the Palliative Medicine Clinic who receive ongoing Palliative Medicine services.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Mark Edwin, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20476549

Mayo Clinic Footer